Another example is the capacity of small-molecule γ-secretase inhibitors to increase expression of BCMA on multiple myeloma cells by preventing cleavage of the antigen from the cell surface [57] (Figure 1D). This evidence concerns the gene TNFRSF17 and AL amyloidosis.